If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPantheon International Regulatory News (PIN)

Share Price Information for Pantheon International (PIN)

Share Price is delayed by 15 minutes
Get Live Data
385.50    -6.00 (-1.53%)
Bid:
389.00
Ask:
390.00
Spread: 1.00 (0.257%)
Market Cap: £1.53b
PIN Live PriceLast checked at - London Stock Exchange

Intraday Pantheon International Share Chart

Monthly Performance Update

25 Mar 2014 07:00

PANTHEON INTERNATIONAL PARTICIPATIONS PLC - Monthly Performance Update

PANTHEON INTERNATIONAL PARTICIPATIONS PLC - Monthly Performance Update

PR Newswire

London, March 24

25th March 2014 Pantheon International Participations PLC Performance update at 28th February 2014 Pantheon International Participations PLC ("PIP") announces an unaudited netasset value ("NAV") per share at 28th February 2014 of 1,331.2p, an increase of25.3p (1.9%) from the NAV per share at 31st January 2014. Valuation gains inthe month accounted for 43.9p (3.4%) of the increase in NAV per share but werepartially offset by adverse foreign exchange movements of -17.6p (-1.3%). PIP's valuation policy for private equity funds is based on the latestvaluations reported by the managers of the funds in which PIP has holdings. Inthe case of PIP's valuation at 28th February 2014, the majority of reportedvaluations (accounting for circa 76% by value) are dated 31st December 2013. At 28th February 2014, PIP's private equity assets stood at £803m, with cashbalances of £88m. Undrawn commitments to investments stood at £183m at 28thFebruary 2014, calculated using exchange rates at that date. In addition, theCompany's multi-currency revolving credit facility agreement, comprising aUS$82m facility and a €57m facility, remained completely undrawn. PIP's portfolio generated net cash of £12.4m during the month, withdistributions of £14.7m relative to £2.3m of calls from existing commitments toprivate equity funds. PIP finalised one new investment during the month, a £1.7m co-investmentalongside ABRY Partners in Aegis Sciences Corporation, a specialty toxicologylaboratory providing a range of testing services. PIP has committed a total of£102m to new investments in the financial year to date. Monthly Report The February monthly newsletter can be accessed on PIP's website atwww.pipplc.com in the Investor Relations section under the heading"Reports & Newsletters", or by following this link:http://www.pipplc.com/investor-relations/financial-reports. Ends NOTES PIP PIP is a London quoted investment trust, managed by Pantheon Ventures (UK) LLP("Pantheon"), one of the longest-established international private equityfund-of-funds managers, investing in both primary funds and secondarytransactions. With investments in private equity funds, covering multipleprivate equity strategies ranging from investments in late stage buyouts toearly stage technology, PIP enables individuals as well as institutions to gainaccess to a substantial portfolio of unquoted companies in the USA, the UK,Continental Europe and Asia, within funds managed by experienced private equitymanagers. PIP may occasionally acquire direct holdings in unquoted companies,usually where a vendor is seeking to sell a combined portfolio of funds anddirect holdings. PIP's investment policy also extends to investing directly incompanies where there is a private equity manager well known to the Companyinvesting on the same terms. Pantheon Pantheon has been active in private equity since 1982 and is now one of theworld's leading private equity fund-of-funds managers, with £16.9bn undermanagement (as at 30th September 2013). Pantheon's offices are located inLondon, San Francisco, New York and Hong Kong, and it has made investments inover 1,000 funds globally. For more information please visit PIP's website at www.pipplc.com or contact: Andrew Lebus or Alexis Barling Pantheon 020 7484 6200 Neither the contents of the Company's website nor the contents of any websiteaccessible from hyperlinks on the Company's website (or any other website) isincorporated into, or forms part of this announcement. Pantheon International Telephone +44 (0) 20 Participations PLC 7484 6200 Norfolk House Facsimile +44 (0)20 7484 6201 31 St. James's Square E-mail: London SW1Y 4JR pip.ir@pantheon.com Internet: www.pipplc.com Registered office: Beaufort House, 51 New North Road, Exeter, Devon EX4 4EP.Incorporated in England number: 2147984. An investment company under section 833 of the Companies Act 2006. Managed byPantheon Ventures (UK) LLP.
Date   Source Headline
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 202610:30 amRNSTotal Voting Rights
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:01 amRNSHalf-year Financial Report
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:01 amRNSMonthly Performance Update
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNSReduced management fee arrangement
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 202611:19 amRNSTotal Voting Rights
2nd Feb 20267:00 amRNSTransaction in Own Shares
30th Jan 20267:00 amRNSTransaction in Own Shares
29th Jan 20267:01 amRNSMonthly Performance Update
29th Jan 20267:00 amRNSTransaction in Own Shares
28th Jan 20267:00 amRNSTransaction in Own Shares
27th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20267:00 amRNSTransaction in Own Shares
23rd Jan 20267:00 amRNSTransaction in Own Shares
22nd Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
16th Jan 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.